Acarbose presents in vitro and in vivo antileishmanial activity against Leishmania infantum and is a promising therapeutic candidate against visceral leishmaniasis
Authors (first, second and last of 21)
Medical Microbiology and Immunology covers all aspects of the interrelationship between infectious agents and their hosts. Among the major topics covered are microbial and viral pathogenesis and the immunological host response to infections. The journal also publishes information from other fields of microbiology, including mycology and parasitology.
In 1886, Medical Microbiology and Immunology was founded by Robert Koch and Carl Flügge, who shaped the journal as Editors-in-Chief for more than 20 years. Originally named “Zeitschrift für Hygiene”, it was renamed multiple times in the light of scientific and medical advances and the emergence of new research disciplines, before adopting its current name Medical Microbiology and Immunology in 1971. See "Journal History" under additional information on the right hand side to learn more.
- Covers the interrelationship between infectious agents and their hosts
- Explores all major topics in the discipline
- Publishes information from related fields
Journal information
- Editors-in-Chief
-
- Volkhard A. J. Kempf,
- Matthias J. Reddehase,
- Christian Bogdan
- Publishing model
- Hybrid (Transformative Journal). Learn about publishing Open Access with us
Journal metrics
- 1.961 (2019)
- Impact factor
- 2.464 (2019)
- Five year impact factor
- 38 days
- Submission to first decision
- 128 days
- Submission to acceptance
- 184,089 (2020)
- Downloads
Latest issue
Latest articles
-
-
Evaluation of a laboratory-based high-throughput SARS-CoV-2 antigen assay for non-COVID-19 patient screening at hospital admission
Authors (first, second and last of 11)
-
-
-
Evaluation of 5 commercial assays for the detection of Mycoplasma genitalium and other Urogenital Mycoplasmas
Authors (first, second and last of 5)
Journal updates
-
Announcement: COVID-19 impact on peer review
As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
-
Publish with us
We advance infectious disease research since 1886
-
VIEW EDITORS
Learn more about our Editors!
-
About this journal
- Electronic ISSN
- 1432-1831
- Print ISSN
- 0300-8584
- Abstracted and indexed in
-
- AGRICOLA
- BIOSIS
- Biological Abstracts
- CAB Abstracts
- CNKI
- Chemical Abstracts Service (CAS)
- Current Contents/ Life Sciences
- Dimensions
- EBSCO Academic Search
- EBSCO Biomedical Reference Collection
- EBSCO Discovery Service
- EBSCO Environment
- EBSCO STM Source
- EMBASE
- Elsevier Biobase
- Google Scholar
- Institute of Scientific and Technical Information of China
- Japanese Science and Technology Agency (JST)
- Journal Citation Reports/Science Edition
- Medline
- Meta
- Naver
- OCLC WorldCat Discovery Service
- Pathway Studio
- ProQuest Agricultural & Environmental Science Database
- ProQuest Algology, Mycology and Protozoology Abstracts (Microbiology C)
- ProQuest Bacteriology Abstracts (Microbiology B)
- ProQuest Biological Science Database
- ProQuest Central
- ProQuest Environmental Science
- ProQuest Genetics Abstracts
- ProQuest Health & Medical Collection
- ProQuest Health Research Premium Collection
- ProQuest Immunology Abstracts
- ProQuest Medical Database
- ProQuest Natural Science Collection
- ProQuest Pharma Collection
- ProQuest Public Health Database
- ProQuest Research Library
- ProQuest SciTech Premium Collection
- ProQuest Virology and AIDS Abstracts
- ProQuest-ExLibris Primo
- ProQuest-ExLibris Summon
- Reaxys
- SCImago
- SCOPUS
- Science Citation Index
- Science Citation Index Expanded (SciSearch)
- TD Net Discovery Service
- UGC-CARE List (India)
- Copyright information